Target Name: LOC105376548
NCBI ID: G105376548
Review Report on LOC105376548 Target / Biomarker Content of Review Report on LOC105376548 Target / Biomarker
LOC105376548
Other Name(s): uncharacterized LOC105376548 | LOC105376548 variant X3 | Uncharacterized LOC105376548, transcript variant X3

LOC105376548: A Potential Drug Target or Biomarker

LOC105376548 is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and biology have made it an attractive target for researchers to study and potentially develop new treatments.

The protein LOC105376548 is a member of the T-cell receptor (TCR) family, which is a critical signaling pathway in the immune system. TCRs are responsible for recognizing and responding to foreign substances in the body, including viruses and bacteria. LOC105376548 is a type of TCR that is expressed in many different tissues and cells in the body, including the brain, heart, and gastrointestinal tract.

One of the key features of LOC105376548 is its unique shape and composition. LOC105376548 has a long, linear amino acid sequence that is rich in charged and polar amino acids, such as Asp, Glu, and Lys. This charged and polar structure is believed to play a key role in the protein's stability and function.

In addition to its unique shape, LOC105376548 has also been identified for its ability to interact with other proteins. LOC105376548 has been shown to interact with several different proteins, including the protein known as PD-L1. PD-L1 is a protein that is expressed in many different types of cancer, and has been shown to play a key role in the development and progression of these diseases. LOC105376548 has also been shown to interact with the protein known as NF-kappa-B, which is a protein that is involved in inflammation and immune responses.

The potential implications of LOC105376548 as a drug target or biomarker are significant. If LOC105376548 is able to be successfully targeted by drugs, it could potentially be used to treat a wide range of diseases. For example, LOC105376548 has been shown to be involved in the development and progression of cancer, and could potentially be used to treat this disease. In addition, LOC105376548 has also been shown to be involved in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. If LOC105376548 is able to be targeted by drugs in these diseases, it could potentially be used to treat the symptoms and potentially slow the progression of these diseases.

Another potential application of LOC105376548 as a drug target or biomarker is its potential as a diagnostic tool. The protein's unique structure and biology make it an attractive target for researchers to study and develop new diagnostic tests. For example, LOC105376548 could potentially be used to diagnose neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.

In conclusion, LOC105376548 is a protein that has been identified as a potential drug target or biomarker for a wide range of diseases. Its unique shape and composition, as well as its ability to interact with other proteins, make it an attractive target for researchers to study and potentially develop new treatments. Further research is needed to fully understand the potential implications of LOC105376548 as a drug target or biomarker.

Protein Name: Uncharacterized LOC105376548

The "LOC105376548 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376548 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185 | LOC105377207 | LOC105377253 | LOC105377262 | LOC105377267 | LOC105377272 | LOC105377273 | LOC105377276 | LOC105377280 | LOC105377282 | LOC105377290 | LOC105377294 | LOC105377296 | LOC105377304 | LOC105377306 | LOC105377313 | LOC105377323 | LOC105377329 | LOC105377347 | LOC105377352 | LOC105377363 | LOC105377364 | LOC105377369 | LOC105377374 | LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643